Filing Details
- Accession Number:
- 0001209191-13-023348
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-01 16:27:36
- Reporting Period:
- 2013-04-29
- Filing Date:
- 2013-05-01
- Accepted Time:
- 2013-05-01 16:27:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1502917 | Christiana Stamoulis | C/O Vertex Pharmaceuticals Incorporated 130 Waverly St. Cambridge MA 02139 | Svp, Corp Strategy & Bus Devlp | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-04-29 | 65,624 | $34.57 | 111,336 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-04-29 | 12,375 | $33.82 | 123,711 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-04-29 | 25,302 | $79.08 | 98,409 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-04-29 | 57,697 | $79.69 | 40,712 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-04-30 | 1 | $34.57 | 40,713 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-04-30 | 1 | $77.88 | 40,712 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2013-04-29 | 65,624 | $0.00 | 65,624 | $34.57 |
| Common Stock | Stock Option (right to buy) | Disposition | 2013-04-29 | 12,375 | $0.00 | 12,375 | $33.82 |
| Common Stock | Stock Option (right to buy) | Disposition | 2013-04-30 | 1 | $0.00 | 1 | $34.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,376 | 2019-10-04 | No | 4 | M | Direct | |
| 5,625 | 2020-07-13 | No | 4 | M | Direct | |
| 9,375 | 2019-10-04 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 797 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Ms. Stamoulis's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $79.08 (range $78.36 to $79.34).
- Ms. Stamoulis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $79.69 (range $79.35 to $80.29).
- Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 10/05/2009.
- Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/14/2010.
Billionaire Hedge Funds
